Literature DB >> 27007970

Targeted Therapy Alone for Acute Promyelocytic Leukemia.

Francesco Lo-Coco1, Laura Di Donato2, Richard F Schlenk3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27007970     DOI： 10.1056/NEJMc1513710

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias.

Authors:  Cécile Esnault; Ramy Rahmé; Kim L Rice; Caroline Berthier; Coline Gaillard; Samuel Quentin; Anne-Lise Maubert; Scott Kogan; Hugues de Thé
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

Review 2.  The genomics of acute myeloid leukemia in children.

Authors:  Shannon E Conneely; Rachel E Rau
Journal:  Cancer Metastasis Rev       Date:  2020-03       Impact factor: 9.264

3.  Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.

Authors:  Xiaoling Wang; Yun Tan; Yizhen Li; Jingming Li; Wen Jin; Kankan Wang
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

4.  Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity.

Authors:  Amin Sobh; Alex Loguinov; Gulce Naz Yazici; Rola S Zeidan; Abderrahmane Tagmount; Nima S Hejazi; Alan E Hubbard; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

Review 5.  Acute promyelocytic leukemia: preventing early complications and late toxicities.

Authors:  Sameem Abedin; Jessica K Altman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.

Authors:  Sandra Cantilena; Luca Gasparoli; Deepali Pal; Olaf Heidenreich; Jan-Henning Klusmann; Joost H A Martens; Alexandre Faille; Alan J Warren; Mawar Karsa; Ruby Pandher; Klaartje Somers; Owen Williams; Jasper de Boer
Journal:  Clin Transl Med       Date:  2022-06

7.  Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial.

Authors:  Senlin Luo; Jidong Tian; Xiao Sun; Feifeng Wu; Ying Liu; Wuqing Wan; Zhou She; Chuan Wen
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-05       Impact factor: 2.650

Review 8.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

9.  Successful treatment of acute promyelocytic leukemia in a 92-year-old man using all-trans retinoic acid combined with oral arsenic: A case report.

Authors:  Xiaowei Shi; Shuangyue Li; Shanhao Tang; Ying Lu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

10.  Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.

Authors:  Jacob L Glass; Andriy Derkach; Patrick Hilden; Amber King; Susan K Seo; Katya Ahr; Ashwin Kishtagari; Ross L Levine; Martin S Tallman; Dan Douer
Journal:  Leuk Res       Date:  2021-03-31       Impact factor: 3.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.